Enzyme-linked immunosorbent assay (ELISA) systems are efficacious in the quantification of antibody levels to IBD, facilitate the monitoring of immune status in flocks, and aid in determining the appropriate time for vaccination.
The IDEXX Infectious Bursal Disease Test’s ELISA has an extended titer range to allow for the differentiation of IBD viruses and enhanced detection of IBD variant strains.